Canaccord Genuity Downgrades UiPath to Hold, Raises Price Target to $17

Benzinga · 1d ago
Canaccord Genuity analyst Kingsley Crane downgrades UiPath (NYSE:PATH) from Buy to Hold and raises the price target from $15 to $17.